MONTREAL, March 26, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-US) specialty pharmaceutical company, announced today the launch of Minjuvi ® ...

“The treatment of DLBCL has significantly evolved in recent years, particularly in the relapse/refractory setting ... the Minjuvi and Monjuvi logos and the “triangle” design are registered ...

The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, reflecting a robust CAGR of 26.2%.

Buried by the algorithm, these Netflix comedies are sharp, strange, and smarter than most prestige TV — it’s time they got ...

He was arrested 4 times for driving drunk, had his license revoked. Drunk again last week, he killed a woman in a horrible traffic accident.

Researchers with City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United ...

In a recent article published in Nature Cancer, a multi-institutional research team led by The University of Osaka describes ...

Canada announced that Health Canada has expanded the marketing authorization for HyQvia for chronic inflammatory demyelinating ...

While a significant number of patients can be cured with standard front-line therapy, many will develop refractory disease or relapse following an initial response, and these individuals are often ...

EastEnders ’ Linda Carter ( Kellie Bright) made a huge decision about her future on Wednesday as she sought to put a traumatic few years behind her. Earlier this week, fans of the BBC soap saw sisters ...

A letter from Dr. Paula Riggs, Professor, Psychiatry. You’ve probably heard a lot about the youth mental health crisis and the opioid epidemic. But what’s often missing from the conversation ...